{
    "eid": "2-s2.0-85016492874",
    "title": "Time-kill study of the in vitro antimicrobial activity of tedizolid against methicillin-resistant Staphylococcus aureus",
    "cover-date": "2017-01-01",
    "subject-areas": [
        {
            "$": "Pharmacology",
            "@code": "3004"
        },
        {
            "$": "Pharmaceutical Science",
            "@code": "3003"
        }
    ],
    "keywords": [
        "Methicillin-resistant Staphylococcus aureus",
        "Tedizolid",
        "Time-kill curve experiments"
    ],
    "authors": [
        "Tanawat Nunart"
    ],
    "citedby-count": 3,
    "ref-count": 19,
    "ref-list": [
        "Result of Antimicrobial Resistance Surveillance",
        "Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [1]",
        "Linezolid resistance in a clinical isolate of Staphylococcus aureus",
        "Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci",
        "In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains",
        "Comparative in Vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges",
        "Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea",
        "Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Kill Curves versus MIC",
        "Pharmacokinetic-pharmacodynamic modeling of the in vitro activities of oxazolidinone antimicrobial agents against methicillin-resistant Staphylococcus aureus",
        "24Th Informational Supplement",
        "Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains",
        "Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guidelines M26-A",
        "Integration of pharmacokinetic/pharmacodynamic modeling and simulation in the development of new anti-infective agents - minimum inhibitory concentration versus time-kill curves",
        "Comparative activities of TR-700 (Torezolid) against staphylococcal blood isolates collected in spain",
        "Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: The ESTABLISH-1 randomized trial",
        "Comparative efficacies of human simulated exposures of tedizolid and linezolid against Staphylococcus aureus in the murine thigh infection model",
        "50Th Interscience Conference on Antimicrobial Agents and Chemotherapy",
        "Skin and soft tissue concentrations of tedizolid (formerly torezolid), a novel oxazolidinone, following a single oral dose in healthy volunteers",
        "Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University"
    ]
}